ReviewFrontiers in immunology2026
Regulatory T cells in pregnancy disorders: a multi-dimensional framework for biomarkers and therapeutic strategies.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pregnancy represents a unique immunological state in which the maternal immune system must maintain tolerance toward the semi-allogeneic fetus while preserving protective immunity against pathogens. Regulatory T cells (Tregs) are central to this balance, coordinating immune suppression, tissue remodeling, and vascular adaptation throughout gestation. Increasing evidence implicates Treg dysregulation in pregnancy disorders, including recurrent pregnancy loss, preeclampsia, and spontaneous preterm labor. Notably, pathological alterations extend beyond changes in cell abundance and involve multi-dimensional defects in suppressive function, lineage stability, spatial distribution, and regulatory signaling. Advances in high-dimensional immune profiling, including single-cell, spatial, and multi-omics approaches have revealed substantial heterogeneity in Treg populations at the maternal-fetal interface and enabled identification of immune signatures with diagnostic and prognostic potential. These insights are reshaping biomarker development from static measurements toward functionally and spatially resolved immune profiling. In this review, we propose a stage-specific and multi-dimensional framework for understanding Treg biology in pregnancy and systematically compare Treg alterations across major pregnancy disorders. We further evaluate the translational potential of circulating and decidual Treg signatures as biomarkers and discuss emerging therapeutic strategies aimed at restoring immune tolerance. Taken together, this framework positions Treg biology as a foundation for biomarker-guided diagnosis and mechanism-based therapeutic interventions in pregnancy complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.